Provided by Tiger Fintech (Singapore) Pte. Ltd.

Trevi Therapeutics, Inc.

5.96
-0.1100-1.81%
Post-market: 5.960.00000.00%19:39 EDT
Volume:3.29M
Turnover:19.72M
Market Cap:710.10M
PE:-13.40
High:6.19
Open:6.09
Low:5.85
Close:6.07
Loading ...
Mar 16, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 18, 2020

Major Issues Report

Current report, items 5.02 and 9.01
Feb 13, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 31, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 06, 2020

Major Issues Report

Current report, item 5.02
Nov 14, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Sep 24, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Aug 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 02, 2019

Major Issues Report

Current report, item 5.02
Jun 14, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jun 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jun 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 04, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 09, 2019

Major Issues Report

Current report, items 5.03 and 9.01